Genomic Biomarkers Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET INTRODUCTION

Genomic biomarkers are Deoxyribonucleic acid (DNA) and Ribonucleic acid (RNA) characteristics used as disease characterization, an indicator of diagnosis, and therapy selection. These biomarkers reflect biological and pathogenic processes and response to therapeutic or other intervention. They are variants in the DNA code that, alone or in combination, enable early detection of disease by predicting its risk and improves patient treatment by monitoring the outcomes.

MARKET DYNAMICS

The rising burden of chronic diseases (cardiovascular diseases, cancer, strokes, and arthritis), high demand for minimally invasive procedures, and technological advancements will spur the demand of the genomic biomarkers market. However, high cost, complex development process, stringent government regulations and lack of standardized means to validate the marker may restraint the growth of the market in the forecasted period. Additionally, development in R&D, and the infrastructure for data sharing and the demand for personalized medicines will boost the growth of the market in the forecasted period.

MARKET SCOPE

The "Global Genomic Biomarkers Market Analysis to 2031" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of genomic biomarkers market with detailed market segmentation the area of type, application, and geography. The global genomic biomarkers market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading genomic biomarkers market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global genomic biomarkers market is segmented on the type, and application. Based on the type, the genomic biomarkers market is segmented into oncology, cardiovascular diseases, neurological diseases, and others. Based on application, the global genomic biomarkers market is segmented into diagnostic and research laboratories, hospitals, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global genomic biomarkers market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The genomic biomarkers market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting genomic biomarkers market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the genomic biomarkers market in these regions.

Genomic Biomarkers Market Report Analysis

Genomic Biomarkers Market

• 
  CAGR (2023 - 2031)

  XX%
• Market Size 2023
  US$ XX Million
• Market Size 2031
  US$ XX Million

Report Coverage

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope

• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis

• Industry landscape and competition analysis & recent developments
• Detailed company profiles

• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

• Thermo Fisher Scientific
• F. Hoffmann-La Roche Ltd
• Aepodia
• Myriad Genetics, Inc
• Eurofins Scientific
• QIAGEN
• Bio-Rad Laboratories, Inc
• Exact Sciences Corporation
• Liquid Genomics, Inc,

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

By Type

• Oncology
• Cardiovascular diseases
• Neurological diseases

By Application

• Diagnostic and Research Laboratories
• Hospitals

MARKET PLAYERS

The reports cover key developments in the genomic biomarkers market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from genomic biomarkers market are anticipated to lucrative growth opportunities in the future with the rising demand for genomic biomarkers in the global market. Below mentioned is the list of few companies engaged in the genomic biomarkers market.

The report also includes the profiles of key genomic biomarkers market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

•   Thermo Fisher Scientific
  
•   F. Hoffmann-La Roche Ltd
  
•   Aepodia
  
•   Myriad Genetics, Inc
  
•   Eurofins Scientific
  
•   QIAGEN
  
•   Bio-Rad Laboratories, Inc
  
•   Exact Sciences Corporation
  
•   Liquid Genomics, Inc,
  
•   Epigenomics
  

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Genomic Biomarkers Market Report Scope